Study of the Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) in a Community-Based, Non-Randomized, Open-Label Trial in Children to Assess Safety and Herd Immunity for the Control of Epidemic Influenza

National Institute of Allergy and Infectious Diseases (NIAID)1 site in 1 country15,000 target enrollmentAugust 31, 2001

ConditionsInfluenza

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: Influenza
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Enrollment: 15000
Locations: 1
Status: Completed
Last Updated: 15 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study tests the safety and effectiveness of a flu vaccine in school children.

School children are usually the first members of a community to come down with the flu, and they often give the flu to their younger siblings, parents, and grandparents. It is hoped that giving school children a flu vaccine can help prevent the spread of the flu to other members of the community.

Detailed Description

This is a Phase III trial (an advanced study with a large number of patients). Your child will receive a single dose of flu vaccine, which is given by a nasal spray.

Registry

clinicaltrials.gov

Start Date

August 31, 2001

End Date

November 2005

Last Updated

15 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Eligibility Criteria

Inclusion Criteria

•Your child may be eligible for this study if he/she:
•Is between the ages of 18 months and 18 years, with consent of parent or guardian.
•Is a resident of the Temple-Belton, Texas area.